Quick Dispatch:
Your new self tirzepatide F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your new self tirzepatide F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy ships.
Need Help?
Questions about new self tirzepatide F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for new self tirzepatide F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy in your area.
Eli Lilly has launched new self-pay options for tirzepatide, introducing 7.5 mg and 10 mg single-dose vials for $499 through the Zepbound Self Pay Journey Program. This initiative, available exclusively via LillyDirect
21.58
Tirzepatide
23.76
Lilly launches lower-price weight-loss drug Zepbound without injector pen
23.58
New Pricing, Access to Tirzepatide Available Through Self-Pay Options
26.61
Tirzepatide
28.65
Eli Lilly Launches Self-Pay Vials of Tirzepatide for Patients With Obesity
25.36
Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
28.14
![Victoza Lawsuit [2026 Update]](https://www.torhoermanlaw.com/wp-content/uploads/2021/07/Victoza-Lawsuit-Alleged-Risks-and-Injuries-Linked-to-GLP-1-Weight-Loss-and-Diabetes-Drugs-Torhoerman-Law.jpg)
